Business Wire

ADVA sync solution enables major Chilean telco to roll out 5G-ready network

28.10.2019 15:00:00 EET | Business Wire | Press release

Share

ADVA (FSE: ADV) today announced that its Oscilloquartz synchronization technology is enabling one of Chile’s largest communication service providers (CSPs) to roll out LTE Advanced (LTE-A) connectivity across the country and prepare for 5G. The OSA 5430 Series and OSA 5410 Series of PTP grandmaster clocks and GNSS receivers deliver stringent phase synchronization in the core and in the access network, enabling the company to address rapidly rising customer demand for premium services such as high-definition video streaming. The deployment strengthens ADVA’s position in the market with its timing technology now synchronizing more of Chile’s major CSP networks than any other supplier’s solutions. The network is being installed by ADVA’s long-term partner Sistemas de Instrumentación Ltda.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191028005386/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

The OSA 5430 Series and OSA 5410 Series are enabling one of Chile’s largest CSPs to roll out national LTE-A connectivity (Photo: Business Wire)

“Being selected to transform the sync network of another of Chile’s key CSPs highlights the unique benefits of our grandmaster clocks and GNSS receiver portfolio. With high-quality oscillators guaranteeing unbeatable holdover and the continual assurance of in-service sync with our built-in probes, our technology offers the most complete and comprehensive solution for advanced timing in telecom networks. It will generate value for years to come,” said Gil Biran, general manager, Oscilloquartz. “Our mission is to provide exceptional service to all of our customers. With our technology and ongoing support, we’re empowering another major company to reshape Chile’s telecommunication landscape, reaching more people than ever while continuing to deliver unrivalled quality of service.”

By deploying the small yet versatile OSA 5410 Series in the access networks, the CSP is providing advanced, time-sensitive mobile connectivity throughout Chile, including previously underserved regions. At once a mini-grandmaster, boundary clock, slave device and sync probe, ADVA’s multipurpose devices lead the industry in terms of adaptability and innovation. At its core, the company is utilizing the OSA 5430 Series, which offers full hardware redundancy, significantly reducing downtime. This high-capacity unit also provides unprecedented scale, supporting speeds of up to 10Gbit/s. Additionally, the OSA 5410 and 5430 both support assisted partial timing support (APTS) and feature Oscilloquartz’s best-in-class oven-controlled crystal oscillators, which offer exceptional holdover performance even in the most challenging conditions.

"We work closely with our partner ADVA to deliver world-class technology that ensures unbeatable quality and availability. Their Oscilloquartz grandmasters are the most advanced timing solutions on the market. Ideal for distributing ultra-precise, incredibly reliable phase and time-of-day information, these devices are now providing the heartbeat of another of Chile’s leading CSPs,” commented Danor Quinteros, CEO, Sistemas de Instrumentación Ltda. “One of the crucial elements of this deployment was bringing synchronization close to the end user where it’s most needed. The compact and feature-rich OSA 5410 devices in the access network and the high-capacity OSA 5430 in the core infrastructure will be key to delivering ever-faster speeds and latency-sensitive applications.”

About ADVA

ADVA is a company founded on innovation and focused on helping our customers succeed. Our technology forms the building blocks of a shared digital future and empowers networks across the globe. We’re continually developing breakthrough hardware and software that leads the networking industry and creates new business opportunities. It’s these open connectivity solutions that enable our customers to deliver the cloud and mobile services that are vital to today’s society and for imagining new tomorrows. Together, we're building a truly connected and sustainable future. For more information on how we can help you, please visit us at: www.adva.com.

About Oscilloquartz

Oscilloquartz is a pioneer in time and frequency synchronization. We design, manufacture and deploy end-to- end synchronization systems that ensure the delivery and assurance of highly precise timing information over next-generation packet and legacy networks. As an ADVA Optical Networking company, we're creating new opportunities for tomorrow's networks. For more information, please visit us at: www.oscilloquartz.com.

Published by:

ADVA Optical Networking SE, Munich, Germany

www.adva.com

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

For ADVA press:
Gareth Spence
t +44 1904 699 358
public-relations@adva.com

For ADVA investors:
Stephan Rettenberger
t +49 89 890 665 854
investor-relations@adva.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Murata Launches Ultra-Low Power AMR Sensors to Boost Battery Life in Healthcare and Wearables Devices27.4.2026 05:00:00 EEST | Press release

Murata Manufacturing Co., Ltd. (TOKYO: 6981) (ISIN: JP3914400001) has commenced mass production of its MRMS166R and MRMS168R anisotropic magnetoresistance (AMR) sensors for healthcare, wearable, and IoT devices. The MRMS166R is the first AMR sensor to combine an average current consumption of 20 nA with operation from a 1.2 V supply, enabling extended battery life in coin cell-powered systems. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260413296947/en/ [Murata Manufacturing Co., Ltd.] AMR sensor The devices are solid-state magnetic sensors used for switching applications. They detect the presence or absence of a magnetic field and generate an output signal that system logic uses to control functions such as transitions between active and sleep modes. This enables contactless switching without mechanical components, improving reliability, and supporting sealed, miniaturized designs. Automatic switching between active and

Sun Pharma signs Definitive Agreement to Acquire Organon27.4.2026 02:51:00 EEST | Press release

Sun Pharmaceutical Industries Limited(Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) (together with its subsidiaries and/or associated companies, “Sun Pharma”) and Organon & Co. (NYSE: OGN) (“Organon”) today announced that they have entered into a definitive agreement under which Sun Pharma will acquire all outstanding shares of Organon for US$ 14.00 per share in an all‑cash transaction with an enterprise valuation of US$ 11.75 billion. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260426881370/en/ Organon is a global healthcare company formed through a spinoff from Merck, known as MSD outside of the United States and Canada, in 2021. Organon has a legacy of deep trust and strong brand equity among HCPs, patients, regulators and other stakeholders. A global leader in women’s health, the company’s portfolio includes more than 70 products across Women’s Health and General Medicines, which includes biosimila

PMC Organometallix Announces Price Increase on All Products25.4.2026 00:02:00 EEST | Press release

Due to significant changes in market conditions, PMC Organometallix, Inc. announces that effective May 1, 2026, or as contracts permit, prices across all product lines globally will increase by 10-25%. This adjustment is driven by sustained cost pressures from key inputs including rising raw material costs and escalating freight and logistics expenses. While the company has been absorbing these increases, the current economic environment brought on by the geopolitical crisis of the Iran conflict requires this adjustment to continue providing the high-quality, consistent materials and supply reliability that customers expect. PMC Organometallix will implement these changes in a transparent, collaborative manner and values your partnership while navigating these economic challenges. Customers with questions or to discuss a specific situation should contact their account representative. About PMC Group PMC Group is a growth-oriented, diversified, global chemicals and plastics company deli

Frankfurt Higher Regional Court upholds BESREMi ® arbitral award in favor of AOP Health24.4.2026 19:52:00 EEST | Press release

Today, the Higher Regional Court of Frankfurt upheld the February 20251 partial final ICC arbitral award in favor of AOP Orphan Pharmaceuticals GmbH (“AOP Health”) in its dispute with PharmaEssentia Corp. (“PharmaEssentia”). The ruling confirms the award which found the Taiwanese company to be liable for certain damages. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260424005227/en/ Portrait Dr. Rudolf Widmann, Founder AOP Health Credit: AOP Health/Daniel Ospelt Dr. Rudolf Widmann, one of the two founders of AOP Health, explains: “We very much welcome the Frankfurt Higher Regional Court’s decision that confirms our position. In the interest of our patients, we are dedicated to maintaining stable and sustainable access to BESREMi® and to responsibly navigating future challenges.” The Product in Dispute The conflict centers around BESREMi® (ropeginterferon alfa-2b), a product launched in 2019 and developed by AOP Health into

Compass Pathways Announces FDA Granted NDA Rolling Review Request and Awarded Commissioner's National Priority Voucher24.4.2026 17:37:00 EEST | Press release

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced the U.S. Food and Drug Administration (FDA) granted Compass NDA rolling review request and selected COMP360, Compass’ proprietary formulation of synthetic psilocybin, for the Commissioner's National Priority Voucher (CNPV) program for treatment-resistant depression (TRD). Companies selected for the voucher program will be entitled to benefits including enhanced communications and a shortened 1-2 month review time following filing of a New Drug Application (NDA), while maintaining FDA’s rigorous safety and efficacy standards. “We are honored and grateful to be selected for the CNPV which is a clear validation of both the urgent unmet need facing millions of people living with treatment resistant depression and the innovative science of COMP360,” said Kabir Nath, Chief Executive Officer of Compass Pathways. “As the most advan

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye